Results 191 to 200 of about 4,347,639 (355)
Protecting vulnerable children: parental drivers of COVID-19 vaccine uptake in children with pediatric cancers [PDF]
Jeanine P. D. Guidry +7 more
openalex +1 more source
Therapeutic cancer vaccines and combination immunotherapies involving vaccination
Trang Nguyen,1 Julie Urban,1 Pawel Kalinski1–5 1Department of Surgery, 2Department of Immunology, 3Department of Microbiology and Infectious Disease, 4Department of Bioengineering, University of Pittsburgh, 5University of Pittsburgh Cancer ...
Urban J, Nguyen T, Kalinski P
core
mRNA-based cancer vaccines for cancer immunotherapy: current progress, challenges, and emerging opportunities [PDF]
Shweta Kulshreshtha +5 more
openalex +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Targeting Epstein-Barr Virus for Cancer Vaccines: Recent Advances and Future Directions. [PDF]
Lin G, Chen Z, Zhong Q, Sun C, Zeng MS.
europepmc +1 more source
Advances in mRNA Cancer Vaccines: Mechanisms, Clinical Progress and Future Outlook
Fengyi Hou
openalex +2 more sources
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source

